Are animal models predictive for humans?
Open accessThe DOI matches its Crossref record; 77 of the 79 references it cites were found in a registry or an index.
Abstract
It is one of the central aims of the philosophy of science to elucidate the meanings of scientific terms and also to think critically about their application. The focus of this essay is the scientific term predict and whether there is credible evidence that animal models, especially in toxicology and pathophysiology, can be used to predict human outcomes. Whether animals can be used to predict human response to drugs and other chemicals is apparently a contentious issue. However, when one empirically analyzes animal models using scientific tools they fall far short of being able to predict human responses. This is not surprising considering what we have learned from fields such evolutionary and developmental biology, gene regulation and expression, epigenetics, complexity theory, and comparative genomics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“first because referencing practices are suboptimal (compare e.g. the data and figures from [5, 72, 73, 77].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditional two-dimensional cell cultures and in vivo animal studies fail to fully recapitulate human cardiac physiology, highlighting the urgent need for more relevant human-based models.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as Shanks et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulatory and research leaders are increasingly taking notice of the issue.”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Even if the design and conduct of an animal experiment are sound and standardized, the translation of its results to the clinic may fail because of disparities between the animal experimental model and the human condition.21”
From The Flaws and Human Harms of Animal Experimentation (2015) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · cited 1×
“The response of different humans to the same drug or disease is a well-known example of this phenomenon [7-13].”
Bleyl, D. W. R. (1989) · Food / Nahrung · doi:10.1002/food.19890330516 · Cited by 2,305
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 2×
“The Olson study [78] purports (and has certainly been cited in this regard) to provide evidence of the vast predictive utility of animal models in assessing human toxicity.”
IARC monographs on the evaluation of carcinogenic risks to humans
(1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90053-7 · Cited by 1,447
Casarett and Doull's toxicology
ed, T. (2015) · Cited by 1,127
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Bruder, C. E. G., Piotrowski, A., Gijsbers, A. A. C. J., Andersson, R., Erickson, S., Diaz de Ståhl, T., Menzel, U., Sandgren, J., von Tell, D., Poplawski, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.011 · Cited by 599 · cited 1×
“The response of different humans to the same drug or disease is a wellknown example of this phenomenon [7-13].”
Failing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599 · cited 1×
“Figures vary, and are controversial, but it now appears that apparently less than 1% of people who took rofecoxib experienced a heart attack or stroke as a result, yet it was also withdrawn [35].”
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Research works printed but not linked: 14
- Greek R Greek J Specious Science 2002 New York: Continuum Int
- Salmon W Curd M, Cover J, Norton Rational Prediction Philosophy of Science 1998 433 444
- Uehling M Microdoses of Excitement over AMS, 'Phase 0' Trials Bio-IT World 2006 2006
- Greek J Greek R What Will We Do if We Don't Experiment on Animals. Continuum 2004
- Sankar U The Delicate Toxicity Balance in Drug Discovery The Scientist 2005 19 32
- Tomatis L Wilbourn L Iversen Evaluation of carcinogenic risk to humans: the experience of IARC New Frontiers in Cancer Causation 2003 Washington, DC: Taylor and Francis 371 387
- Caldwell J Jakoby W Comparative Aspects of Detoxification in Mammals Enzymatic Basis of Detoxification 1980 1 New York: Academic Press
- Clemmensen J Hjalgrim-Jensen S Alex Pub On the absence of carcinogenicity to man of phenobarbital Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Coulston F, Shubick S 251 265
- Clayson D Coulston F, Shubick P The carcinogenic action of drugs in man and animals Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Ablex Pub 185 195
- Anisimov V Molecular and Physiological Mechanisms of Aging 2003 St Petersburg: Nauka
- Kolata G 2 Top Diet Drugs Are Recalled Amid Reports of Heart Defects New York Times. New York 1997
- Shanks N Greek R Nobis N Greek J Animals and Medicine: Do Animal Experiments Predict Human Response? Skeptic 2007 13 44 51
- Conn P Parker J Letter. Animal research wars Skeptic 2007 13 18 19
- Morange M A successful form for reductionism The Biochemist 2001 23 37 39
Cited by
Items 201–300 of 778
The History and Implications of Testing Thalidomide on Animals
Greek, R., Shanks, N., & Rice, M. J. (2011) · The Journal of Philosophy Science & Law · doi:10.5840/jpsl20111133 · Cited by 38
“Having examined the general aspects of animal-based research and testing in other publications [1, 2], we will very briefly outline those arguments before examining the thalidomide issue.”
BackgroundSelf-citationMaiga, M. C., Ahidjo, B. A., Maïga, M., & Bishai, W. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02145-15 · Cited by 38
“Since a high proportion of new drug candidates in development fail to advance to clinical use (16), the FIG 1 Evaluation of roflumilast in murine models of tuberculosis reveals that this PDE4-I does not affect the mean survival times of tuberculous in BALB/c mice (A) or lung TNF- and IFN- levels during treatment (B).”
BackgroundMiędzybrodzki, R., Kasprzak, H., Letkiewicz, S., Rogóż, P., Żaczek, M., Thomas, J., & Górski, A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad516 · Cited by 37
Foster, J. R., Lund, G. A., Sapelnikova, S., Tyrrell, D. L., & Kneteman, N. M. (2013) · Xenobiotica · doi:10.3109/00498254.2013.867553 · Cited by 37
“…has been a considerable and ongoing debate as to how, or even if, results from animal studies can be extrapolated to potential toxicity in man (Shanks et al., 2009) and the science of risk assessment has grown up on the understanding that a direct extrapolation between laboratory animal…”
BackgroundShortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue
Fine, B. M., & Vunjak‐Novakovic, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00662 · Cited by 37
In Vitro Blood–Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device
Choi, J., Santhosh, M., & Choi, J.-W. (2019) · Micromachines · doi:10.3390/mi11010021 · Cited by 37
Dempsey, N., & Blau, S. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110140 · Cited by 37
Pompei, M., & Pompei, F. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1370-7 · Cited by 37
Prediction of clinical risks by analysis of preclinical and clinical adverse events
Clark, M. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.02.008 · Cited by 36
Engineered biomaterials in stem cell-based regenerative medicine
Zhu, F., Nie, G., & Liu, C. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad027 · Cited by 38
Stefaniak, F. (2015) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00077 · Cited by 36
“Moreover, animal models are frequently poorly correlated with response on humans (Knight, 2007; Shanks et al., 2009).”
BackgroundLiver-on-a-chip: Considerations, advances, and beyond
Yang, Z., Liu, X., Cribbin, E. M., Kim, A. M., Li, J. J., & Yong, K. (2022) · Biomicrofluidics · doi:10.1063/5.0106855 · Cited by 36
Greek, R., & Hansen, L. A. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.06.002 · Cited by 38
Self-citationMonsanto, S. P., Hintze, K. J., Ward, R. E., Larson, D. P., Lefevre, M., & Benninghoff, A. D. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.06.002 · Cited by 36
Yu, K., Nadanaciva, S., Rana, P., Lee, D. W., Ku, B., Roth, A., Dordick, J. S., Will, Y., & Lee, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2126-3 · Cited by 35
Characterization of glioblastoma spheroid models for drug screening and phototherapy assays
Alves, S. R., Calori, I. R., Bi, H., & Tedesco, A. C. (2022) · OpenNano · doi:10.1016/j.onano.2022.100116 · Cited by 35
Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models
Tse, G., Li, K. H. C., Cheung, C. K. Y., Letsas, Κ. P., Bhardwaj, A., Sawant, A. C., Liu, T., Yan, G., Zhang, H., Jeevaratnam, K., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.620539 · Cited by 34
Musso, N., Stracquadanio, S., Costantino, A., Lazzaro, L., Stefani, S., & Bongiorno, D. (2021) · Pathogens · doi:10.3390/pathogens10020239 · Cited by 35
“Their system is the first biomimetic human in vitro osteomyelitis model to allow understanding of the early stages of disease progression and to overcome the limitations of other model systems, for example: (a) results of animal models are often not transferable to human beings [20,122], while their bone marrow model…”
BackgroundResultMorais, A. D. S., Oliveira, J. M., & Reis, R. L. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-76735-2_19 · Cited by 34
The ethics of animal research: a survey of the public and scientists in North America
Joffe, A. R., Bara, M., Anton, N., & Nobis, N. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0100-x · Cited by 33
Comte, B., Baumbach, J., Benis, A., Basílio, J., Debeljak, N., Flobak, Å., Franken, C., Harel, N., HeFeng, F. Q., Kuiper, M. T. R., et al. (2020) · Network and Systems Medicine · doi:10.1089/nsm.2020.0004 · Cited by 33
Stem cells based in vitro models: trends and prospects in biomaterials cytotoxicity studies
Ahmed, U., Ahmed, R., Masoud, M. S., Tariq, M., Ashfaq, U. A., Augustine, R., & Hasan, A. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe6d8 · Cited by 34
Zhao, Q., Cole, T., Zhang, Y., & Tang, S. (2021) · Micromachines · doi:10.3390/mi12070765 · Cited by 33
Khan, I., Kumari, P., Kumar, R., Khatri, D. K., & Singh, S. B. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2108454 · Cited by 33
“Hence, it is easy and safe to examine potential novel therapies for plausible therapeutic effects (Shanks et al. 2009, Green et al. 2018, Singh et al. 2022).”
Wiedemann, P., & Schütz, H. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0881-y · Cited by 33
Li, Y., Pi, Q., Wang, P., Liu, L., Han, Z., Shao, Y., Zhai, Y., Zuo, Z., Gong, Z., Yang, X., et al. (2017) · RSC Advances · doi:10.1039/c7ra11357a · Cited by 33
In vitro assessment for cytotoxicity screening of new antimalarial candidates
Espíndola, M. R., Varotti, F. D. P., Aguiar, A. C. C., Andrade, S. N., & da Rocha, E. M. M. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e18308 · Cited by 32
Sargeant, T. J., & Fourrier, C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.09.015 · Cited by 32
Progress in bioprinting technology for tissue regeneration
Sabzevari, A., Pisheh, H. R., Ansari, M., & Salati, A. (2023) · Journal of Artificial Organs · doi:10.1007/s10047-023-01394-z · Cited by 32
“Cell-filled printed biological scaffolds provide better spatial depth and cell-to-cell interaction, enhancing body-like physiology, and everyday intercellular interactions [23].”
BackgroundPharmacologic studies in vulnerable populations: Using the pediatric experience
Zimmerman, K. O., González, D., Swamy, G. K., & Cohen‐Wolkowiez, M. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.08.007 · Cited by 32
“depending on the species of the experimental animal, this testing did not reliably predict the teratogenic nature of thalidomide.(4) Animal studies have similarly been of limited”
Ko, J. E., Ko, Y., Kim, W. I., Kwon, O. H., & Kwon, O. H. (2016) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33726 · Cited by 32
Calotropis - A multi-potential plant to humankind: Special focus on its wound healing efficacy
Ali‐Seyed, M., & Ayesha, S. (2020) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2020.101725 · Cited by 32
Animal Models in an Age of Personalized Medicine
Greek, R., Menache, A., & Rice, M. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.89 · Cited by 32
Self-citationAnimal Models of Human Disease
Green, S. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009025836 · Cited by 31
Kondō, M., Yamato, M., Takagi, R., Murakami, D., Namiki, H., & Okano, T. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34849 · Cited by 31
The methodological quality of animal research in critical care: the public face of science
Bara, M., & Joffe, A. R. (2014) · Annals of Intensive Care · doi:10.1186/s13613-014-0026-8 · Cited by 31
“Given the generally poor translation rate of AR to human medicine [6-8,13-18,27,55,56] (e.”
Cardiac gene therapy: are we there yet?
Matkar, P. N., Leong-Poi, H. M., & Singh, K. K. (2016) · Gene Therapy · doi:10.1038/gt.2016.43 · Cited by 32
Enright, H. A., Felix, S. H., Fischer, N. O., Mukerjee, E. V., Soscia, D. A., McNerney, M. W., Kulp, K. S., Zhang, J., Page, G. G., Miller, P. E., et al. (2016) · The Analyst · doi:10.1039/c5an01728a · Cited by 31
Chin, E., & Goh, E. L. K. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.06.003 · Cited by 31
State-of-the-Art Metabolic Toxicity Screening and Pathway Evaluation
Hvastkovs, E. G., & Rusling, J. F. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04772 · Cited by 31
Kim, H., Lee, S., Lim, J., Yoo, J., & Hwang, D. (2020) · Cell Proliferation · doi:10.1111/cpr.12965 · Cited by 30
Khan, K., Ahram, D. F., Liu, Y. P., Westland, R., Sampogna, R. V., Katsanis, N., Davis, E. E., & Sanna‐Cherchi, S. (2021) · Kidney International · doi:10.1016/j.kint.2021.09.034 · Cited by 30
Circadian hormone control in a human-on-a-chip: In vitro biology’s ignored component?
Cyr, K. J., Avaldi, O. M., & Wikswo, J. P. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217732766 · Cited by 31
Mizuno, T., Tsukiya, T., Takewa, Y., & Tatsumi, E. (2017) · Journal of Artificial Organs · doi:10.1007/s10047-017-1003-4 · Cited by 30
Stojkovska, J., Zvicer, J., & Obradović, B. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10521-2 · Cited by 30
“…capable of demonstrating, among other things, immune responses and nanoparticle distribution in the organism, but at the same time, these studies are expensive, complex for interpretation, and raise ethical issues and questions of the relevance of animal models to humans (e.g., Shanks et al. 2009).”
BackgroundAlshaibani, D. A., Kamadjaja, M. J. K., Sitalaksmi, R. M., Ridwаn, R. D., Algabri, R., Zafar, M. S., Ramalingam, S., & Alqutaibi, A. Y. (2025) · BMC Oral Health · doi:10.1186/s12903-025-06368-6 · Cited by 29
The Trouble with Animal Models in Brain Research
Johnson, L. S. M. (2020) · Advances in neuroethics · doi:10.1007/978-3-030-31011-0_16 · Cited by 29
Ocular translational science: A review of development steps and paths
Mann, B. K., Stirland, D. L., Lee, H., & Wirostko, B. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.012 · Cited by 29
“With all in vivo studies, there are ethical concerns about the need to use animals for the studies and whether the animal models can accurately predict results in humans [43].”
BackgroundScott, L. L., & Downing, T. G. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-9996-5 · Cited by 29
Evaluation of human primary intestinal monolayers for drug metabolizing capabilities
Speer, J. E., Wang, Y., Fallon, J. K., Smith, P. C., & Allbritton, N. L. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0212-1 · Cited by 29
Fleming, J. W., Capel, A. J., Rimington, R. P., Player, D. J., Stolzing, A., & Lewis, M. P. (2019) · Cytoskeleton · doi:10.1002/cm.21553 · Cited by 28
Hall, D. A., Ray, J., Watson, J., Sharman, A., Hutchison, J., Harris, P. A., Daniel, M., Millar, B., & Large, C. H. (2019) · Hearing Research · doi:10.1016/j.heares.2019.03.018 · Cited by 28
Wang, Y., Shang, F., Liu, W., Jia, C., Luo, L., Wang, H., Min, X., Xu, J.-H., Ma, L., & Yang, X.-M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262589 · Cited by 28
“Currently, nine out of ten experimental drugs fail in clinical studies because we cannot accurately predict how they will behave in people based on laboratory and animal studies (Shanks et al., 2009).”
BackgroundBioinspired in vitro microenvironments to control cell fate: focus on macromolecular crowding
Zeugolis, D. I. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00380.2020 · Cited by 28
Risk of cancer in long‐term levothyroxine users: Retrospective population‐based study
Wu, C., Islam, M. M., Nguyen, P., Poly, T. N., Wang, C., Iqbal, U., Li, Y., & Yang, H. (2021) · Cancer Science · doi:10.1111/cas.14908 · Cited by 28
Tissue engineering of the gastrointestinal tract: the historic path to translation
Collier, C. A., Mendiondo, C., & Raghavan, S. A. (2022) · Journal of Biological Engineering · doi:10.1186/s13036-022-00289-6 · Cited by 27
Organ-on-a-Chip for Drug Screening: A Bright Future for Sustainability? A Critical Review
Feitor, J. F., Brazaca, L. C., Lima, A. M., Ferreira, V. G., Kassab, G., Bagnato, V. S., Carrilho, E., & Cardoso, D. R. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01454 · Cited by 27
Cho, S., Sun, Y., Soisson, A. P., Dodson, M. K., Peterson, C. M., Jarboe, E. A., Kennedy, A., & Janat-Amsbury, M. M. (2013) · PubMed · Cited by 27
Li, Y., Wang, P., Hu, C., Wang, K., Chang, Q., Liu, L., Han, Z., Shao, Y., Zhai, Y., Zuo, Z., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20445-7 · Cited by 27
Divergent Solutions to Visual Problem Solving across Mammalian Species
Mustafar, F., Harvey, M., Khani, A., Arató, J., & Rainer, G. (2018) · eNeuro · doi:10.1523/eneuro.0167-18.2018 · Cited by 27
Banerjee, S. K., Huckuntod, S. D., Mills, S. D., Kurten, R. C., & Pechous, R. D. (2019) · Infection and Immunity · doi:10.1128/iai.00175-19 · Cited by 27
Scientific assessments in European food law: Making it future-proof
de Boer, A. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104437 · Cited by 27
Ringwald, K. G., Pfarr, J., Stein, F., Brosch, K., Meller, T., Thomas‐Odenthal, F., Meinert, S., Waltemate, L., Breuer, F., Winter, A., et al. (2022) · Human Brain Mapping · doi:10.1002/hbm.25869 · Cited by 26
“The question remains whether this also applies to humans (Shanks et al., 2009).”
BackgroundExtracellular Microenvironmental Control for Organoid Assembly
Sullivan, K. M., Ko, E. C., Kim, E. M., Ballance, W. C., Ito, J. D., Chalifoux, M., Kim, Y. J., Bashir, R., & Kong, H. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0186 · Cited by 26
“As such, much of the research on brain organoids are divided into three directions: (1) growth of morphologically correct tissue to understand function and synaptic activity, (2) recapitulation of the blood-brain barrier, and (3) development of the strategies to treat neurodegenerative diseases and acute/traumatic bra…”
Sagers, J. E., Brown, A. S., Vasilijić, S., Lewis, R. M., Şahin, M. İ., Landegger, L. D., Perlis, R. H., Kohane, I. S., Welling, D. B., Patel, C. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23609-7 · Cited by 26
Senior, P. A., & Pettus, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13846 · Cited by 26
van Hoorn, C. E., Hoeks, S. E., Essink, H. M., Tibboel, D., & de Graaff, J. C. (2019) · Pediatric Anesthesia · doi:10.1111/pan.13553 · Cited by 27
Mouse avatars of human cancers: the temporality of translation in precision oncology
Green, S., Dam, M. S., & Svendsen, M. N. (2021) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-021-00383-w · Cited by 26
Kim, H., & Park, H. (2025) · Toxicological Research · doi:10.1007/s43188-024-00275-8 · Cited by 25
REPEATED COLLECTION OF VAGINAL SMEAR CAUSES STRESS IN MICE
Eren-Koçak, E., Bahadır-Varol, A., & Esen, E. C. (2022) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28099 · Cited by 25
Jeon, H., Kim, D., Yoo, J., & Kwon, S. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.04.027 · Cited by 25
Colombani, T., Rogers, Z. J., Bhatt, K., Sinoimeri, J., Gerbereux, L., Hamrangsekachaee, M., & Bencherif, S. A. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.021 · Cited by 25
González, D., Boggess, K., & Cohen‐Wolkowiez, M. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000743 · Cited by 25
“For example, animal developmental toxicology studies of thalidomide resulted in variable results depending on the species studied and thus proved poorly predictive of toxicity in humans.(7) Of important note, however, the FDA recently amended its regulations regarding product labeling for use in pregnancy and lactatio…”
ResultChoudhary, S., Sun, Q., Mannion, C. M., Kissin, Y., Zilberberg, J., & Lee, W. Y. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0103 · Cited by 25
Chavan, S., Scherbak, N. N., Engwall, M., & Repsilber, D. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00459 · Cited by 24
Irrechukwu, O., Yeager, R., David, R. M., Ekert, J., Saravanakumar, A., & Choi, C. K. (2023) · ALTEX · doi:10.14573/altex.2204071 · Cited by 25
“Moreover, current industry and regulatory paradigms rely largely on animal studies that are hampered by poor preclinical to clinical translation (Bailey et al., 2015; Clark and Steger-Hartmann, 2018; Monticello et al., 2017; Shanks et al., 2009).”
BackgroundMomoli, C., Costa, B., Lenti, L., Tubertini, M., Parenti, M., Martella, E., Varchi, G., & Ferroni, C. (2025) · Cancers · doi:10.3390/cancers17040700 · Cited by 24
“Although animal models have been extensively used in cancer-drug development, the low success rates in translating preclinical findings from animals to effective clinical treatments have raised growing concerns about their reliability as predictors of human responses [10,11].”
Rosbach, K., Williams, M. D., Gillenwater, A. M., & Richards-Kortum, R. R. (2012) · Translational Oncology · doi:10.1593/tlo.11310 · Cited by 24
“A potential advantage of studying optical imaging approaches in freshly resected human tissue as an alternative to in vivo assessments in animal models is that the pattern of biomarker expression and the potential barriers to topical administration of imaging agents will likely be more physiologically relevant to the…”
From replica to instruments: animal models in biomedical research
Germain, P. (2014) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-014-0007-0 · Cited by 24
“…similarity should instead be with respect to the features under investigation.2 Most philosophers appear to endorse this conception of modelling through local/ partial similarity, most explicitly Steel (2008), Shelley (2010), Piotrowska (2012), LaFollette and Shanks (1996), Shanks et al. (2009).”
In vitro three‐dimensional culture systems of salivary glands
Tanaka, J., & Mishima, K. (2020) · Pathology International · doi:10.1111/pin.12947 · Cited by 24
Translational biomedicine in action: Constructing biomarkers across laboratory and benchside
Crabu, S. (2016) · Social Theory & Health · doi:10.1057/sth.2015.35 · Cited by 24
“From a scientific perspective, this argument has been justified by claiming the weakness of experimenting on animal models for the production of clinically relevant evidence (Contopoulos-Ioannidis et al, 2003; Butler, 2008; Shanks et al, 2009).”
BackgroundComputational translation of drug effects from animal experiments to human ventricular myocytes
Tveito, A., Jæger, K. H., Maleckar, M. M., Giles, W. R., & Wall, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-66910-0 · Cited by 23
Sethi, A., Ahmad, M., Huma, T., & Ahmad, W. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1944398 · Cited by 23
“…of 5-FU loaded MMWCH-NPs and 5-FU loaded GA-co-MMWCH-NPs formulations under microscopic examination no clear cut lesions were shown in Figure 9 insignificant pathological variations were showed in islets of Langerhans of pancreatic tissues slides of rabbits (Shanks et al., 2009; Shayne, 2009).”
BackgroundPotential Teratogenic Effects of Clomiphene Citrate
Scaparrotta, A., Chiarelli, F., & Verrotti, A. (2017) · Drug Safety · doi:10.1007/s40264-017-0546-x · Cited by 23
“At the same time, although there are elements of poor practice that are real, large animals have worked exceptionally well as predictive models for humans, when properly used’’ [48].”
BackgroundMelong, N., Steele, S. L., MacDonald, M., Holly, A. C., Collins, C. C., Zoubeidi, A., Berman, J. N., & Dellaire, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-14413-w · Cited by 23
Piktel, J. S., & Wilson, L. D. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00135 · Cited by 23
Characterization of 3D-Bioprinted In Vitro Lung Cancer Models Using RNA-Sequencing Techniques
Zou, S., Ye, J., Wei, Y., & Xu, J. (2023) · Bioengineering · doi:10.3390/bioengineering10060667 · Cited by 22
“Moreover, animal models do not respond to predicting human toxicology and pathology [19].”
BackgroundChua, C. J., Morrissette-McAlmon, J. B. F., Tung, L., & Boheler, K. R. (2023) · Genes · doi:10.3390/genes14101864 · Cited by 22
“However, human cardiac disorders are often complex, polygenic conditions that are strongly influenced by environmental and genetic factors [190].”
BackgroundNugraha, B., Mohr, M. A., Ponti, A., Emmert, M. Y., Weibel, F., Hoerstrup, S. P., Moll, S., Certa, U., Prunotto, M., & Pantazis, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12683-y · Cited by 22
Yin, R., Luo, Z., Zhuang, P., Lin, Z., & Kwoh, C. K. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa901 · Cited by 22
A systematic review on thyroid organoid models: time-trend and its achievements
Samimi, H., Atlasi, R., Parichehreh-Dizaji, S., Khazaei, S., Rahnama, M. A., Seifirad, S., & Haghpanah, V. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00479.2020 · Cited by 22
Scaffold-based and scaffold-free cardiac constructs for drug testing
Arai, K., Kitsuka, T., & Nakayama, K. (2021) · Biofabrication · doi:10.1088/1758-5090/ac1257 · Cited by 22
Ren, B., Wu, Q., Muskhelishvili, L., Davis, K. J., Wang, Y., Rua, D., & Cao, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052593 · Cited by 22
Weuve, J. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu153 · Cited by 22
Merotto, E., Pavan, P. G., & Piccoli, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061742 · Cited by 21
“All of these aspects not only make 3D bioprinting the means that, in the future, will allow the construction of patient-specific organs useful for transplantation purposes, but it is an in vitro approach that exceeds standard 2D culture techniques [10] and can also eliminate the usual adoption for animal tests, also a…”
BackgroundMetabolomics in the pharmaceutical industry
Reily, M. D., & Tymiak, A. A. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.03.001 · Cited by 21
Wellbourne-Wood, J., & Chatton, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00098 · Cited by 21
Desmoulin‐Canselier, S., & Moutaud, B. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00051 · Cited by 21
On balance: weighing harms and benefits in fundamental neurological research using nonhuman primates
Árnason, G., & Clausen, J. (2015) · Medicine Health Care and Philosophy · doi:10.1007/s11019-015-9663-4 · Cited by 21
Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
Moustaqil, M. D., Gambin, Y., & Sierecki, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072301 · Cited by 21
Metadata
- Authors
- Shanks, N., Greek, R., & Greek, J.
- Affiliations
- Wichita State University (US)
- Corresponding author
- Greek, Ray
- Venue
- Philosophy, Ethics, and Humanities in Medicine
- Published
- 2009-01-15
- Volume
- 4
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1747-5341 (ISSN-L)
- PMC
- PMC2642860
- OpenAlex
- W2030932194
- Cited by
- 677
- References
- 79
- Citations by year
- 2026: 18 · 2025: 38 · 2024: 53 · 2023: 43 · 2022: 66 · 2021: 69 · 2020: 69 · 2019: 64 · 2018: 67 · 2017: 47 · 2016: 37 · 2015: 35 · 2014: 19 · 2013: 21 · 2012: 13
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Philosophy Ethics and Humanities in Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WBI Studies Repository (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- animal models, predictive validity, animal-to-human extrapolation, toxicology, pathophysiology, drug response prediction, scientific terminology, epigenetics, comparative genomics, complexity theory, evolutionary biology, developmental biology, gene expression regulation
- MeSH terms
- Animals, Forecasting, Humans, Models, Animal, Animal Experimentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.